[
    [
        {
            "time": "2020-08-01",
            "original_text": "身处优质赛道，口腔医疗服务龙头通策医疗上半年净利1.45亿，第二季度省内省外花开正盛丨领航100",
            "features": {
                "keywords": [
                    "通策医疗",
                    "口腔医疗服务",
                    "净利",
                    "第二季度",
                    "省内省外"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "口腔服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-08-01",
            "original_text": "【面包财经】通策医疗：2020年上半年归母净利润1.45亿元，同比下降30.22% 盈利能力下降",
            "features": {
                "keywords": [
                    "通策医疗",
                    "归母净利润",
                    "同比下降",
                    "盈利能力"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【面包财经】通策医疗：2020年上半年归母净利润1.45亿元，同比下降30.22% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-08-01",
            "original_text": "通策医疗：2020年上半年归母净利润1.45亿元，同比下降30.22% 盈利能力下降",
            "features": {
                "keywords": [
                    "通策医疗",
                    "归母净利润",
                    "同比下降",
                    "盈利能力"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-08-01",
            "original_text": "通策医疗(600763)：公司二季度单季业绩恢复增长 全年增长可期",
            "features": {
                "keywords": [
                    "通策医疗",
                    "二季度",
                    "单季业绩",
                    "恢复增长",
                    "全年增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-08-01",
            "original_text": "兴证医药2020年8月投资月报：再论大创新时代的创新疫苗",
            "features": {
                "keywords": [
                    "兴证医药",
                    "创新疫苗",
                    "投资月报"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]